Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10099734 | 0.71 | HSP90AA1 (0.31) | — | |
| SCHEMBL17385233 | 0.70 | FNTA (0.53) | — | |
| SCHEMBL11039302 | 0.70 | CYP19A1 (0.32) | CYP3A4 | |
| SCHEMBL1994837 | 0.70 | CYP19A1 (0.32) | CYP3A4 | |
| SCHEMBL10099743 | 0.70 | — | — | |
| SCHEMBL12359650 | 0.68 | — | — | |
| SCHEMBL2254556 | 0.68 | — | — | |
| SCHEMBL2254553 | 0.68 | — | — | |
| SCHEMBL11257689 | 0.66 | LMNA (0.40) | CYP3A4 | |
| SCHEMBL16405067 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10472463-B2 | Resin, composition and use | DSM IP ASSETS B.V. (NL) | 2019-11-12 | — | — | US | disclosed |
| US-20170129992-A1 | RESIN, COMPOSITION AND USE | COVESTRO (NETHERLANDS) B.V. (NL) | 2017-05-11 | — | — | US | disclosed |
| US-20170129992-A1 | RESIN, COMPOSITION AND USE | COVESTRO (NETHERLANDS) B.V. (NL) | 2017-05-11 | — | — | US | disclosed |
| WO-2015193493-A1 | RESIN, COMPOSITION AND USE | DSM IP ASSETS B.V. (NL) | 2015-12-23 | — | — | WO | disclosed |
| US-8110695-B2 | Compounds and compositions containing silicon and/or other heteroatoms and/or metals and methods of making and using them | WELKER MARK E (US) | 2012-02-07 | — | — | US | disclosed |
| US-20100056801-A1 | Compounds And Compositions Containing Silicon And/Or Other Heteroatoms And/Or Metals And Methods of Making And Using Them | WELKER MARK E | 2010-03-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10472463-B2 | Resin, composition and use | AKR1C3, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, AKR1C4 | CYP3A4 1487/4885 |
| US-20100056801-A1 | Compounds And Compositions Containing Silicon And/Or Other Heteroatoms And/Or Metals And Methods of Making And Using Them | CA6, SOD1, CA1 | CYP3A4 538/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.